Canada markets open in 4 hours 22 minutes

Keros Therapeutics, Inc. (KROS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
60.26-0.31 (-0.51%)
At close: 04:00PM EDT
62.52 +2.26 (+3.75%)
After hours: 04:55PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
151
151
0
20,100
0
Operating Expenses
Research Development
135,258
135,258
87,265
55,143
33,860
Selling General and Administrative
34,834
34,834
27,525
21,330
12,797
Total Operating Expenses
167,692
167,692
107,709
76,473
44,197
Operating Income or Loss
-167,541
-167,541
-107,709
-56,373
-44,197
Interest Expense
0
0
1
4
6
Total Other Income/Expenses Net
14,549
14,549
3,031
-356
-1,330
Income Before Tax
-152,992
-152,992
-104,679
-56,733
-45,533
Income Tax Expense
0
0
0
2,011
-172
Income from Continuing Operations
-152,992
-152,992
-104,679
-58,744
-45,361
Net Income
-152,992
-152,992
-104,679
-58,744
-45,361
Net Income available to common shareholders
-152,992
-152,992
-104,679
-58,744
-45,361
Basic EPS
-4.96
-
-4.15
-2.52
-2.93
Diluted EPS
-4.96
-
-4.15
-2.52
-2.93
Basic Average Shares
28,751
-
25,241
23,334
15,506
Diluted Average Shares
28,751
-
25,241
23,334
15,506